Bigul

Concord Biotech Ltd - 543960 - Correction In Dividend % Mentioned In The Outcome Of Board Meeting Held Today I.E. Thursday, May 23, 2024- Audited Financial Results For The Quarter And Financial Year Ended On March 31, 2024

The Board of Directors ("the Board") as its meeting held on 23rd May, 2024 has recommended Dividend of Rs. 8.75 (@30%) per Equity Share of Face Value of Re. 1 Each Fully paid up for the Financial Year 2023-24, subject to approval by shareholders of the company at the ensuing AGM Due to typographical error the % was mentioned as 30% instead of 875% which is the correct figure.
23-05-2024
Bigul

Concord Biotech Ltd - 543960 - Corporate Action-Board approves Dividend

The Board of Directors ("the Board") at its meeting held on 23 May 2024 has recommended dividend of Rs. 8.75 (30%) per equity share of face value of Re. 1 each fully paid up for the financial year 2023-24, subject to approval by shareholders of the company at the ensuing AGM. Due to Typographical error the % was mentioned as 30% instead of 875% which is the correct figure.
23-05-2024
Bigul

Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s

Subject to approval of members at the ensuing annual general meeting and upon recommendation of audit committee of the company, the board had approved appointment of BSR & Co LLP as statutory Auditor of the company for a first term of consecutive 5 Year in place of existing statutory auditors M/s Deloitte Haskins & Sell, Chartered Accountant, whose tenure is expiring at the ensuing Annual general meeting of the company.
23-05-2024
Bigul

Concord Biotech Ltd - 543960 - Record Date For Payment Of Final Dividend

Record date for payment of final dividend
23-05-2024
Bigul

Concord Biotech Ltd - 543960 - Corporate Action-Board approves Dividend

outcome of board meeting held today i.e Thursday may 23, 2024- audited finanical results for the quarter and financial year ended on march 31 2024
23-05-2024
Bigul

Concord Biotech Ltd - 543960 - Outcome Of Board Meeting Held Today I.E. Thursday, May 23, 2024- Audited Financial Results For The Quarter And Financial Year Ended On March 31, 2024

Outcome of Board meeting held today i.e thursday may 23,2024- Audited Financial Results for the quarter and financial year ended on March 31, 20241
23-05-2024
Bigul

Concord Biotech Ltd - 543960 - Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. Thursday, May 23, 2024- Audited Financial Results For The Quarter And Financial Year Ended On March 31, 2024

Outcome of Board Meeting held today i.e. Thursday, May 23, 2024- Audited Financial Results for the quarter and Financial Year ended on March 31, 2024
23-05-2024
Bigul

Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Pursuant to Regulation 30 of the SEBI (LODR) Regulation 2015, as amended from time to time, read with para A of Schedule III thereto, We wish to inform you that the company has arranged Earning Call with Investor/Analyst (Participants) to discuss the standalone and consolidated Financial Results of the Company for the quarter and year ended 31 March 2024 scheduled on Tuesday 28th May, 2024 at 4:00 PM IST. The Earning Call invite is enclosed for your records. Kindly take the same into your records and Oblige
21-05-2024
Bigul

Concord Biotech Ltd - 543960 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015. Intimation About Completion Of Inspection By Saudi Food And Drug Authority At Valthera (Unit II) Of The Company

In compliance with the aforesaid regulation, we hereby notify that the Saudi Food and Drug authority has successfully completed inspection of company''s manufacturing Unit II (formulation facility), located at Valthera, Gujarat from tuesday 14th May 2024 to 16th May, 2024. Kindly take the above information on record.
17-05-2024
Next Page
Close

Let's Open Free Demat Account